| Univariable | Multivariable | ||
---|---|---|---|---|
Mean ± SD Median (IQR) | P-value | Coefficient (95% CI) | P-value | |
Group | ||||
 Active | 3.27 ± 0.88 3 (1) | 0.0001 | Reference | 0.0001 |
 Placebo | 5.87 ± 1.02 6 (2) | 2.58 (2.11, 3.06) | ||
Sex | ||||
 Female | 4.56 ± 1.52 5 (3) | 0.771 | 0.09 (−0.48, 0.65) | 0.761 |
 Male | 4.48 ± 1.83 4 (3) | Reference | ||
Marital Status | ||||
 Single | 4.67 ± 1.58 4 (3) | 0.582 | 0.25 (−0.41, 0.92) | 0.452 |
 Married | 4.45 ± 1.65 4.5 (3) | Reference | ||
Duration of Migraine | ||||
 ≤2 years | 4.58 ± 1.63 4.50 (3) | 0.710 | 0.30 (−0.23, 0.84) | 0.262 |
 > 2 years | 4.46 ± 1.62 4 (3) | Reference | ||
Age (rho) | - 0.05 | 0.711 | 0.02 (−0.02, 0.06) | 0.277 |
BMI (rho) | - 0.06 | 0.648 | - 0.03 (−0.14, 0.08) | 0.567 |
Number of attack pre-treatment (rho) | 0.15 | 0.232 | 0.27 (0.01, 0.54) | 0.007 |